This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jun 20;25(18):2635-6; author reply 2637-8.

doi: 10.1200/JCO.2007.11.4272.

Many new cancer drugs in the United Kingdom are facing negative NICE rulings

Eric Low; Myeloma UK

PMID: 17577049
DOI: 10.1200/JCO.2007.11.4272

Comment

Many new cancer drugs in the United Kingdom are facing negative NICE rulings

Eric Low et al. J Clin Oncol. 2007.

. 2007 Jun 20;25(18):2635-6; author reply 2637-8.

doi: 10.1200/JCO.2007.11.4272.

Authors

Eric Low; Myeloma UK

PMID: 17577049
DOI: 10.1200/JCO.2007.11.4272

No abstract available

PubMed Disclaimer

Comment on

European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF, Mason AR. Drummond MF, et al. J Clin Oncol. 2007 Jan 10;25(2):191-5. doi: 10.1200/JCO.2006.07.8956. J Clin Oncol. 2007. PMID: 17210939 Review.

Similar articles

European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF, Mason AR. Drummond MF, et al. J Clin Oncol. 2007 Jan 10;25(2):191-5. doi: 10.1200/JCO.2006.07.8956. J Clin Oncol. 2007. PMID: 17210939 Review.
American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology. Meropol NJ, et al. J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6. J Clin Oncol. 2009. PMID: 19581533
United healthcare, five oncology practices try bundled payments.
Goozner M. Goozner M. J Natl Cancer Inst. 2011 Jan 5;103(1):8-10. doi: 10.1093/jnci/djq538. Epub 2010 Dec 17. J Natl Cancer Inst. 2011. PMID: 21169535 No abstract available.
How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States.
Ramsey SD. Ramsey SD. J Clin Oncol. 2007 Jan 10;25(2):175-9. doi: 10.1200/JCO.2006.08.9805. J Clin Oncol. 2007. PMID: 17210936 No abstract available.
[Economic evaluation in oncology].
Schöffski O. Schöffski O. Med Klin (Munich). 2000 Jun;95 Suppl 1:14-7. Med Klin (Munich). 2000. PMID: 10941248 Review. German.

See all similar articles

Cited by

Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia?
Chim L, Kelly PJ, Salkeld G, Stockler MR. Chim L, et al. Pharmacoeconomics. 2010;28(6):463-75. doi: 10.2165/11533000-000000000-00000. Pharmacoeconomics. 2010. PMID: 20465315
Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.
Tse VC, Ng WT, Lee V, Lee AW, Chua DT, Chau J, McGhee SM. Tse VC, et al. BMC Cancer. 2011 Jul 9;11:288. doi: 10.1186/1471-2407-11-288. BMC Cancer. 2011. PMID: 21740590 Free PMC article.
Cost-Effectiveness of Novel Agents in Medicare Patients with Multiple Myeloma: Findings from a U.S. Payer's Perspective.
Chen Y, Lairson DR, Chan W, Huo J, Du XL. Chen Y, et al. J Manag Care Spec Pharm. 2017 Aug;23(8):831-843. doi: 10.18553/jmcp.2017.23.8.831. J Manag Care Spec Pharm. 2017. PMID: 28737990 Free PMC article.
Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
Pearson SD. Pearson SD. J Clin Oncol. 2012 Dec 1;30(34):4275-81. doi: 10.1200/JCO.2012.42.6601. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071229 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.